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Abstract
In this article we briefly review the reasons and advantages that underly our publisher's decision to
introduce article-processing charges (APC) for manuscripts submitted to Cell Communication and
Signaling. The charge is an attempt to develop a new business model for distributing biomedical
information and has been accepted in a number of other journals. APCs will enable BioMed Central
to continue to provide their excellent service and will help to establish our journal.
Introduction
Since its inception, Cell Communication and Signaling
(CCS) has been published by BioMed Central as an Open
Access journal. BioMed Central is an independent pub-
lisher committed to ensuring high quality publications in
the fields of biomedical research. Articles published in
CCS  are freely available to everyone online, and are
archived in internationally recognized free repositories.
Although it is still young, CCS has been moderately suc-
cessful, as indicated by the several thousand accesses to
the manuscripts published throughout 2004. Of course,
becoming established will require more years, but the
quality of the publications that have been accepted by our
editorial board is a sign of good health.
Open Access : what is it ? what does it provide ?
Thanks to an Open Access policy, articles that are pub-
lished become freely and instantly available to any person
connecting to the World Wide Web. Because articles are
intended to remain available at no cost forever, they can
be read, downloaded and printed in perpetuity. Copies of
the published manuscripts are also archived and searcha-
ble in PubMed Central [1], the US National Library of
Medicine's full-text repository of life science literature,
and also in repositories at the University of Potsdam [2]
in Germany, at INIST [3] in France and in e-Depot [4], the
National Library of the Netherlands' digital archive of all
electronic publications.
Since the authors hold coyright for their published work,
they can make their articles freely available on their insti-
tution's website. The copyright policy also stipulates that
the authors grant anyone the permission to reproduce and
disseminate the article, provided that no errors are intro-
duced and that it is adequately cited.
As a comparison, several journals now offer free access to
their articles on line, but it is generally, either for a limited
period of time or only after 6 to 12 month following pub-
lication.
Thus, Open Access offers several benefits to authors and
readers in the scientific community and the general pub-
lic. First the authors are assured that their work is widely
disseminated and that it is likely to be cited more often
than when it is published in a journal whose access is lim-
ited to subscribers. At a time when politicians in many dif-
ferent countries are urging the scientific community to
better communicate with the general public, this aspect is
of prime importance.
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Another major consequence is that there is no financial
barrier to the dissemination of knowledge. The impact of
a country's economy on access to knowledge is considera-
ble and is often under evaluated or ignored by those who
live in wealthy environments. As long as a researcher has
Internet access, he or she can read Open Access articles
(although enabling them to get Internet access is, admit-
tedly, a big issue).
Why is there a need for APC ?
Contributing to the cost of publishing by paying APCs is
comparable to paying a toll for driving safely and more
rapidly on good quality highways. Multiple clean, fast and
safe lanes kept in good condition, with same services pro-
vided to all customers.
Any publishing of quality, traditional or electronic,
involves processing that is generally paid by the scientific
community (either as authors, readers or subscribers). It
may seem to some authors that the requested fee of 525
US$ is exceedingly high but, in truth, it is very low com-
pared to the revenues made per article in the traditional
publishing model, which some have suggested were as
high as US$3000, if not higher.
The APC pays for the article to be freely accessible, and for
the processes required before inclusion in PubMed and
archiving in PubMed Central, e-Depot, Potsdam and
INIST. No extra charge applies for color printing. Authors
can circumvent the charge by getting their institution to
become a 'member' of BioMed Central, whereby an
annual membership fee covers the APCs for all authors at
that institution submitting to any journal published by
BioMed Central in that year. Current members include
NHS England, the World Health Organization, the US
National Institutes of Health, Harvard, Princeton and Yale
universities, and all UK universities [5]. No charge is made
for articles that are rejected after peer review. Many fund-
ing agencies have also realized the importance of Open
Access publishing and have specified that their grants may
be used directly to pay APCs [6].
Conclusion
On behalf of the Editorial Board of CCS, I wish to reassure
readers and authors that we are committed to evaluating
manuscripts on the basis of their scientific quality, not on
whether author's can pay article-processing charge. If an
author is unable to afford the APC, the Editor-in-Chief
will be able to waive payment, if deemed necessary.
We hope that introducing APCs does not inhibit authors
from submitting their work. Besides, we firmly believe
that publishing Open Access can only help scientific com-
munication and improve results, hence becoming an
excellent service to society.
We do hope that you will support our effort towards this
end by submitting manuscripts to Cell Communication and
Signaling.
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